We are pleased to announce that the 19th Annual European Life Sciences CEO Forum (#Sachs_ELSF) will take place on the 4th - 5th of March 2026 at the Hilton Zurich Airport Hotel.

The event will be part of the Sachs Spring Life Sciences Week (#SSLSW), which will also incorporate the 1st Annual European Neuroscience Innovation Forum (#Sachs_ENIF). It will be held on the 3rd of March 2026, the day before ELSF, allowing relevant attendees to register for both events.

The main programme for the 19th Annual ELSF is spread over 2 days (4th - 5th of March) and will feature more than 12 hours of high-level keynotes and panel discussions. In addition, there will be a global company showcase of 50+ presentations by established public, private, emerging, and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated presentation tracks, alongside virtual company showcases, which will be available on demand during the virtual week. We anticipate 400+ delegates will register for the forum from all Life Sciences sectors, with the target audience being corporate and financial investors/partners, banks, and advisors, with part of the audience participating virtually.

The In-Person meetings will take place on the 4th - 5th of March, while virtual meetings will occur on the 10th - 12th of March. For the virtual meetings, the system will allow you to have a secure audio/video call, as well as the option to present slides using a screen share function and we will have a dedicated room for in-person meetings. We expect around 2000 meetings to be completed during the event.

The conference will be held in the Central European Time Zone, and the programme will consist of:

Day 1 (Wednesday, 4th of March):

• BioPharma Industry Panel: Outlook for 2026
• Keynote Speech: "Longevity & Healthy Life Span"
• Venture & Private Equity Investor Roundtable
• Platforms & Novel Therapeutics Panel: Emerging Opportunities
• Autoimmune & Inflammatory Diseases Panel: New Approaches
• Obesity & Cardiometabolic Disorders Panel: Innovation & Latest Trends
• Radiopharmaceuticals in Oncology Panel: Next-Gen Therapies & Opportunities

Day 2 (Thursday, 5th of March):

• BioPharma Dealmakers Roundtable: Challenges & Opportunities
• Greater China Biopharma Panel: Driving Cross-Border Dealmaking
• Partnering in Oncology Panel: Latest Developments in BD&L
• Oncology Innovation Panel: Latest Advances in Therapeutics
• Early-Stage Innovation & Investment Panel: Addressing the Funding Gap
• Rising Stars – Biotech Seed Companies Session

In-Person Meetings – 4th - 5th of March
Virtual Meetings via Online Meeting System – 10th - 12th of March
Main Networking Reception – 4th of March
Farewell Reception – 5th of March
On-Demand Content – by 12th of March

SECA members receive a 10% discount

Please find here further information and the registration link.

The event will be part of the Sachs Spring Life Sciences Week, which will also incorporate the 1st Annual European Neuroscience Innovation Forum.